Single-cell irradiation from [²¹¹At]astatine-labeled C215 monoclonal antibody: Improved estimates of radiosensitivity from measurements on cellular uptake and retentionPALM, Stig; BÄCK, Tom; CLAESSON, Ingela et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1219-1221, issn 0250-7005, 3 p.Article

Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extractionBOURGEOIS, Mickaël; GUERARD, Francois; FAIVRE-CHAUVET, Alain et al.Journal of labelled compounds & radiopharmaceuticals. 2008, Vol 51, Num 11-12, pp 379-383, issn 0362-4803, 5 p.Article

A tin precursor for the synthesis of no-carrier-added [*I]MIBG and [²¹¹At]MABGVAIDYANATHAN, Ganesan; AFFLECK, Donna J; ALSTON, Kevin L et al.Journal of labelled compounds & radiopharmaceuticals. 2007, Vol 50, Num 3-4, pp 177-182, issn 0362-4803, 6 p.Article

Cyclotron isotopes and radiopharmaceuticals. XXXV: Astatine-211LAMBRECHT, R. M; SAED MIRZADEH.The International journal of applied radiation and isotopes. 1985, Vol 36, Num 6, pp 443-450, issn 0020-708XArticle

A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapyHUMM, J. L.International journal of radiation oncology, biology, physics. 1987, Vol 13, Num 11, pp 1767-1773, issn 0360-3016Article

Production of [²¹¹At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle TherapyGUERARD, François; GESTIN, Jean-François; BRECHBIEL, Martin W et al.Cancer biotherapy & radiopharmaceuticals. 2013, Vol 28, Num 1, pp 1-20, issn 1084-9785, 20 p.Article

THE IN VIVO FATE OF A ²¹¹AT LABELLED MONOCLONAL ANTIBODY WITH KNOWN SPECIFICITY IN A MURINE SYSTEMVAUGHAN ATM; BATEMAN WJ; FISHER DR et al.1982; INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS; ISSN 0360-3016; USA; DA. 1982; VOL. 8; NO 11; PP. 1943-1946; BIBL. 10 REF.Article

THE SPECIFIC INHIBITION OF CELLULAR CLONOGENIC PROLIFERATION USING ²¹¹AT LABELLED LECTINS AND ANTIBODIES. IVAUGHAN ATM; BATEMAN WJ; BROWN G et al.1982; INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE AND BIOLOGY; ISSN 0047-0740; USA; DA. 1982; VOL. 9; NO 3; PP. 167-171; BIBL. 10 REF.Article

In Vitro Evaluation of Avidin Antibody Pretargeting Using ²¹¹At-Labeled and Biotinylated Poly-L-Lysine as Effector MoleculeFROST, Sofia Hl; JENSEN, Holger; LINDEGREN, Sture et al.Cancer. 2010, Vol 116, Num 4, pp 1101-1110, issn 0008-543X, 10 p., SUPConference Paper

A radio-high-performance liquid chromatography dual-flow cell gamma-detection system for on-line radiochemical purity and labeling efficiency determinationLINDEGREN, S; JENSEN, H; JACOBSSON, L et al.Journal of chromatography. 2014, Vol 1337, pp 128-132, issn 0021-9673, 5 p.Article

Closo-dodecaborate (2-) anion as a potential prosthetic group for attachment of astatine to proteins. Aspects of the labelling chemistry with chloramine-TORLOVA, A; LEBEDA, O; TOLMACHEV, V et al.Journal of labelled compounds & radiopharmaceuticals. 2000, Vol 43, Num 3, pp 251-260, issn 0362-4803Article

Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinomaJUNPING CHENG; EKBERG, Tomas; ENGSTRÖM, Mats et al.The Laryngoscope. 2007, Vol 117, Num 6, pp 1013-1018, issn 0023-852X, 6 p.Article

A kit method for the high level synthesis of [²¹¹At]MABGVAIDYANATHAN, Ganesan; AFFLECK, Donna J; ALSTON, Kevin L et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 10, pp 3430-3436, issn 0968-0896, 7 p.Article

Comparison of ²¹¹At-PRIT and ²¹¹At-RIT of Ovarian Microtumors in a Nude Mouse ModelFROST, Sofia H. L; BÄCK, Tom; CHOUIN, Nicolas et al.Cancer biotherapy & radiopharmaceuticals. 2013, Vol 28, Num 2, pp 108-114, issn 1084-9785, 7 p.Article

²¹¹At-α-dose dependence of poly-ADP-ribosylation of human glioblastoma cells in vitro : Suitability in cancer therapy?SCHNEEWEISS, F. H. A; SHARAN, R. N; BROWN, I et al.Strahlentherapie und Onkologie. 1999, Vol 175, Num 9, pp 458-461, issn 0179-7158Article

Synthesis and biodistribution study of a new ²¹¹At-calix[4]arene complexYORDANOV, Alexander T; DEAL, Kim; GARMESTANI, Kayhan et al.Journal of labelled compounds & radiopharmaceuticals. 2000, Vol 43, Num 12, pp 1219-1225, issn 0362-4803Article

Evaluation of ²¹¹At-labelled monodisperse polymer particles in vivo : Comparison of different specific activitiesLARSEN, R. H; VARAAS, T; HOFF, P et al.Journal of labelled compounds & radiopharmaceuticals. 1996, Vol 38, Num 9, pp 775-784, issn 0362-4803Article

Radiohalogen incorporation into organic systemsBOLTON, R.Journal of labelled compounds & radiopharmaceuticals. 2002, Vol 45, Num 6, pp 485-528, issn 0362-4803Article

Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assayPALM, S; BÄCK, T; CLAESSON, I et al.Anticancer research. 1998, Vol 18, Num 3A, pp 1671-1676, issn 0250-7005Article

Effective treatment of a murine model of adult T-cell leukemia using ²¹¹At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25ZHUO ZHANG; MEILI ZHANG; GARMESTANI, Kayhan et al.Blood. 2006, Vol 108, Num 3, pp 1007-1012, issn 0006-4971, 6 p.Article